tiprankstipranks
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market
Holding CASI?
Track your performance easily

CASI Pharmaceuticals (CASI) Income Statement

448 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q4 2023), CASI Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, CASI Pharmaceuticals's net income was $―. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 34.05M$ 33.88M$ 43.11M$ 30.17M$ 15.14M$ 4.06M
Cost of Revenue
$ 12.07M$ 13.83M$ 15.83M$ 12.56M$ 9.51M$ 3.94M
Gross Profit
$ 21.98M$ 20.05M$ 27.28M$ 17.61M$ 5.63M$ 128.00K
Operating Expense
$ 41.18M$ 45.33M$ 53.77M$ 59.38M$ 56.77M$ 46.75M
Operating Income
$ -19.20M$ -25.28M$ -26.49M$ -41.52M$ -51.53M$ -46.62M
Net Non Operating Interest Income Expense
$ 53.00K$ -614.00K$ 127.00K$ 321.00K$ 866.00K$ -3.00K
Other Income Expense
$ 2.92M$ -1.63M$ 6.43M$ -5.29M$ -5.56M$ 615.00K
Pretax Income
$ -29.88M$ -26.29M$ -38.28M$ -35.84M$ -47.51M$ -46.42M
Tax Provision
$ 1.98M$ -81.00K$ 1.98M-$ -732.00K-
Earnings From Equity Interest Net Of Tax
$ 4.48M$ 566.00K$ 4.48M---
Net Income Common Stockholders
$ -32.42M$ -26.96M$ -41.01M$ -36.65M$ -48.29M$ -46.02M
Basic EPS
$ -1.69$ -2.02$ -3.01$ -2.69$ -44.00-
Diluted EPS
$ -1.69$ -2.02$ -3.01$ -27.00$ -44.00$ -48.00
Basic Average Shares
$ 53.21M$ 13.36M$ 13.65M$ 1.36M$ 1.10M$ 959.48K
Diluted Average Shares
$ 53.21M$ 13.36M$ 13.65M$ 1.36M$ 1.10K$ 959.00
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 76.36M$ 59.16M$ 69.60M$ 71.94M$ 66.28M$ 50.68M
Net Income From Continuing And Discontinued Operation
$ -32.42M$ -26.94M$ -41.01M$ -36.65M$ -48.29M$ -46.02M
Normalized Income
$ -9.89M$ -24.36M$ -25.16M$ -29.70M--
Interest Expense
------
EBIT
$ -29.06M$ -26.34M$ -37.56M$ -35.22M$ -33.31M$ -46.42M
EBITDA
$ -27.07M$ -20.59M$ -35.14M$ -33.40M$ -31.35M$ -44.26M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis